- Revenues of $79.7 Million, Increase of 29% over First Quarter 2008- Earnings Per Share of $0.50 per Basic Share and $0.49 per Diluted Share, Increases of 14% and 20% over First Quarter 2008...
SILVER SPRING, Md., April 29 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today the appointment of Mr. Richard Giltner to its Board of Directors as an...
SILVER SPRING, Md., April 28 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that the U.S. Food and Drug Administration (FDA) will require additional time to...
SILVER SPRING, Md., April 24 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will release its 2009 first quarter financial results before market open...
16 Mar 2009
United Therapeutics Announces Probable Delay in Approval Timeline for Inhaled Treprostinil (Tyvaso)
Conference Call to be Held at 9:00 a.m. Eastern Time on March 16, 2009SILVER SPRING, Md., March 16 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that, based...
- Total Annual Revenues of $281.5 Million- Annual Basic and Diluted Net Loss per Share of $1.87- Annual Earnings Before Non-Cash Charges of $5.20 per Basic Share, or $4.77 per Diluted ShareSILVER...
SILVER SPRING, Md., Feb. 10 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will release its 2008 fourth quarter and annual financial results before...
INDIANAPOLIS and SILVER SPRING, Md., Nov. 17 /PRNewswire-FirstCall/ -- Eli
Lilly and Company (NYSE: LLY) and United Therapeutics Corporation
(Nasdaq: UTHR) today announced that the two companies have...
SILVER SPRING, Md., Oct. 30 /PRNewswire-FirstCall/ -- United Therapeutics
Corporation (Nasdaq: UTHR) today announced its results of operations for the
quarter ended September 30, 2008. Total...
SILVER SPRING, Md., Oct. 23 /PRNewswire-FirstCall/ -- United Therapeutics
Corporation (Nasdaq: UTHR) announced today that it will release its 2008 third
quarter financial results before market open...
SILVER SPRING, Md., Sept. 3 /PRNewswire-FirstCall/ -- United Therapeutics
Corporation (Nasdaq: UTHR) and its wholly-owned subsidiary Lung Rx, Inc.
announced today that the U.S. Food and Drug...